BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20363633)

  • 21. 4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors.
    Salerno S; Barresi E; Amendola G; Berrino E; Milite C; Marini AM; Da Settimo F; Novellino E; Supuran CT; Cosconati S; Taliani S
    J Med Chem; 2018 Jul; 61(13):5765-5770. PubMed ID: 29912561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbonic anhydrase inhibitors: synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Parkkila S; Hilvo M; Supuran CT
    Bioorg Med Chem; 2008 Oct; 16(20):9113-20. PubMed ID: 18819811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.
    Innocenti A; Antel J; Wurl M; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5703-7. PubMed ID: 15482952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity.
    Abdel-Hamid MK; Abdel-Hafez AA; El-Koussi NA; Mahfouz NM; Innocenti A; Supuran CT
    Bioorg Med Chem; 2007 Nov; 15(22):6975-84. PubMed ID: 17822907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.
    Cecchi A; Winum JY; Innocenti A; Vullo D; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5775-80. PubMed ID: 15501039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbonic anhydrase inhibitors. Synthesis of topically effective intraocular pressure lowering agents derived from 5-(omega-aminoalkylcarboxamido)-1,3,4-thiadiazole-2-sulfonamide.
    Barboiu M; Supuran CT; Menabuoni L; Scozzafava A; Mincione F; Briganti F; Mincione G
    J Enzyme Inhib; 2000; 15(1):23-46. PubMed ID: 10850953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, in vitro antibacterial and carbonic anhydrase II inhibitory activities of N-acylsulfonamides using silica sulfuric acid as an efficient catalyst under both solvent-free and heterogeneous conditions.
    Massah AR; Adibi H; Khodarahmi R; Abiri R; Majnooni MB; Shahidi S; Asadi B; Mehrabi M; Zolfigol MA
    Bioorg Med Chem; 2008 May; 16(10):5465-72. PubMed ID: 18439830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbonic anhydrase inhibitors. X-ray crystal studies of the carbonic anhydrase II-trithiocarbonate adduct--an inhibitor mimicking the sulfonamide and urea binding to the enzyme.
    Temperini C; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2010 Jan; 20(2):474-8. PubMed ID: 20005709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of [(2-pyrimidinylthio)acetyl]benzenesulfonamides as inhibitors of human carbonic anhydrases.
    Čapkauskaitė E; Zubrienė A; Baranauskienė L; Tamulaitienė G; Manakova E; Kairys V; Gražulis S; Tumkevičius S; Matulis D
    Eur J Med Chem; 2012 May; 51():259-70. PubMed ID: 22440859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited--old leads for new applications?
    Temperini C; Cecchi A; Scozzafava A; Supuran CT
    Org Biomol Chem; 2008 Jul; 6(14):2499-506. PubMed ID: 18600270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3D-QSAR study of sulfonamide inhibitors of human carbonic anhydrase II.
    Huang H; Pan X; Tan N; Zeng G; Ji C
    Eur J Med Chem; 2007 Mar; 42(3):365-72. PubMed ID: 17118494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes VA and VB over the cytosolic and membrane-associated carbonic anhydrases I, II and IV.
    Smaine FZ; Pacchiano F; Rami M; Barragan-Montero V; Vullo D; Scozzafava A; Winum JY; Supuran CT
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6332-5. PubMed ID: 18990571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX.
    Thiry A; Ledecq M; Cecchi A; Dogné JM; Wouters J; Supuran CT; Masereel B
    J Med Chem; 2006 May; 49(9):2743-9. PubMed ID: 16640335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails.
    Winum JY; Thiry A; Cheikh KE; Dogné JM; Montero JL; Vullo D; Scozzafava A; Masereel B; Supuran CT
    Bioorg Med Chem Lett; 2007 May; 17(10):2685-91. PubMed ID: 17376683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, structure-activity relationship studies, and X-ray crystallographic analysis of arylsulfonamides as potent carbonic anhydrase inhibitors.
    Gitto R; Damiano FM; Mader P; De Luca L; Ferro S; Supuran CT; Vullo D; Brynda J; Rezáčová P; Chimirri A
    J Med Chem; 2012 Apr; 55(8):3891-9. PubMed ID: 22443141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of potent and selective human carbonic anhydrase VII (hCA VII) inhibitors.
    Gitto R; Agnello S; Ferro S; Vullo D; Supuran CT; Chimirri A
    ChemMedChem; 2010 Jun; 5(6):823-6. PubMed ID: 20349499
    [No Abstract]   [Full Text] [Related]  

  • 37. Quantum chemical QSAR models to distinguish between inhibitory activities of sulfonamides against human carbonic anhydrases I and II and bovine IV isozymes.
    Deeb O; Goodarzi M; Khadikar PV
    Chem Biol Drug Des; 2012 Apr; 79(4):514-22. PubMed ID: 22181786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virtual screening-driven identification of human carbonic anhydrase inhibitors incorporating an original, new pharmacophore.
    Pala N; Dallocchio R; Dessì A; Brancale A; Carta F; Ihm S; Maresca A; Sechi M; Supuran CT
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2515-20. PubMed ID: 21420862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency.
    Pacchiano F; Aggarwal M; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT
    Chem Commun (Camb); 2010 Nov; 46(44):8371-3. PubMed ID: 20922253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase inhibitors: Inhibition of the new membrane-associated isoform XV with phenols.
    Innocenti A; Hilvo M; Scozzafava A; Parkkila S; Supuran CT
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3593-6. PubMed ID: 18501600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.